Study title: Open-Label Evaluation of 5% 5. Benzoyl Peroxide/1% Clindamycin Gel used in combination with Tazarotene 0.1% Cream and Oral Minocycline in the treatment of severe acne vulgaris.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Skin and Connective Tissue Diseases [C17] | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: BENZOYLPEROXIDE AND CLINDAMYCIN | |||||
ATC code: D10A X30 | |||||
Document link: Article 45_Ref_U0515_Final for Submission_09Nov2011.xlsx | |||||
Document date: 2013-11-11 | |||||
Study number: UO515 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |